Regulations.gov document
Final COVID-19: Developing Drugs and Biological Products for Treatment or Prevention…
Other · FDA-2020-D-1370 · posted Nov 23, 2023
Key facts
| Document ID | FDA-2020-D-1370-0026 |
|---|---|
| Title | Final COVID-19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-1370 |
| Posted | Nov 23, 2023 |
| Comment period opens | Nov 23, 2023 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: